Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma

This publication has 24 references indexed in Scilit:

• CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
  The Journal of Experimental Medicine, 1989
• Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
  Journal of Clinical Investigation, 1989
• A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
  International Immunology, 1989
• Identification of human erythrocyte blood group antigens on decay- accelerating factor (DAF) and an erythrocyte phenotype negative for daf
  The Journal of Experimental Medicine, 1988
• Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
  Journal of Clinical Investigation, 1988
• Separation of self from non-self in the complement system
  Immunology Today, 1987
• Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
  Journal of Clinical Investigation, 1987
• Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
  The Journal of Experimental Medicine, 1987
• Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells.
  The Journal of Experimental Medicine, 1986
• Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
  The Journal of Experimental Medicine, 1985